As per the report, all the 90 samples, covering 6 variants, tested by these laboratories are clear with lead much below the permissible limits.
Soon Maggi noodles could be available on stands as reports of three laboratories mandated by the Bombay High Court to test the samples have come in favour of the company — Nestle India.
As per the report, all the 90 samples, covering 6 variants, tested by these laboratories are clear with lead much below the permissible limits.
In a press statement issued by the company said: "Nestlé India has always maintained that Maggi Noodles are safe. Nestlé India has conducted over 3,500 tests representing over 200 million packs in both national as well as international accredited laboratories and all reports are clear. In addition to these, various countries, including USA, UK, Singapore, Australia and others have found the noodles manufactured in India safe for consumption."
The company was told to retest the variants of noodle by the high court which had in its order pronounced in August lifted the nation-wide ban imposed on the manufacture and sale of noodles. The court had directed the variants to be tested at three laboratories in Punjab, Jaipur and Hyderabad, to ascertain the amount of lead.
The company said: "Nestle will continue to collaborate with the FSSAI, the apex food regulator and other stakeholders. In compliance with the orders of the High Court, we will now commence manufacture and will start selling only after the newly manufactured products are also cleared by the designated three laboratories. We are committed to reintroduce our beloved Maggi noodles at the earliest."
The company had challenged the order of the FSSAI issued on June 5, banning the noodle after it claimed that test carried out at laboratory indicated a high presence of lead content which is harmful to the health of consumers. The state Food and Drug Administration (FDA) a day later, issued a similar order imposing the ban in Maharashtra.
The bench had in its order ruled that principles of natural justice had not been followed as the company had not been given a show cause notice before imposing the ban. The high court was also of the opinion that laboratory in which Maggi noodles samples were tested were not affiliated to the National Accreditation Board for Testing and Calibration Laboratories (NABL) but were tested at recognized laboratory and those test were not sufficient for imposing the ban.
On Friday shares of Nestle India surged nearly 6 per cent, adding Rs 3,346 crore to its market valuation, after the results of the reports were declared. The stock climbed 5.59 per cent to settle at Rs6,551 on BSE. At NSE, shares of the company jumped 5.84 per cent to end at Rs 6,569.40. Led by gains in the stock, the company''s market valuation rose by Rs 3,345.94 crore to Rs 63,161.94 crore.
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
 "Maggi")
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
)
){kind=small}
){kind=small}
)
)
)
)
)
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}